Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium channels are transmembrane proteins responsible for the rapid influx of sodium ions that initiates action potentials in excitable cells, including neurons and cardiac myocytes. Voltage-gated sodium channels are critical for electrical signaling in both the central and peripheral nervous system. Many drugs, including tricyclic antidepressants such as clomipramine and tetracyclic antidepressants such as maprotiline, exert part of their toxicity and side effects through blockade of these channels. Inhibition of neuronal sodium channels reduces neuronal firing but can, in overdose or with drug interactions, lead to severe cardiac and CNS side effects including arrhythmias, seizures, and death. These channels are targeted both therapeutically (for anesthesia, antiarrhythmics, some anticonvulsants) and as unintended adverse effect sites for certain antidepressants and other medications.
Inhibition (blockade) of voltage-gated sodium channels, reducing neuronal excitability and action potential generation
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium channel protein (neuronal subtype; e.g., voltage-gated sodium channel).